The latest closing stock price for BioNexus Gene Lab as of November 20, 2024 is 0.30.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2023 would have $-950 today, roughly -1 times their original investment - a -94.96% compound annual growth rate over 1 years.
The all-time high BioNexus Gene Lab stock closing price was 5.95 on July 21, 2023.
The BioNexus Gene Lab 52-week high stock price is 3.39, which is 1030% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 0.28, which is 6.7% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 0.54.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2023 would have $-950 today, roughly -1 times their original investment - a -94.96% compound annual growth rate over 1 years.
The all-time high BioNexus Gene Lab stock closing price was 5.95 on July 21, 2023.
The BioNexus Gene Lab 52-week high stock price is 3.39, which is 1030% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 0.28, which is 6.7% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 0.54.